Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can quitting alcohol after heart ablation keep irregular beats away?

NCT ID NCT05510167

Disease control Sponsor: Texas Cardiac Arrhythmia Research Foundation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are testing whether reducing alcohol intake after catheter ablation helps people with atrial fibrillation. The trial enrolls 184 patients who regularly drink more than five alcoholic drinks per week and are scheduled for their first ablation. Participants are asked to either abstain completely or limit themselves to two or fewer drinks per week for eight months. The study measures whether the irregular heartbeat returns, and tracks changes in quality of life and cognitive function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a behavioral program asking participants to abstain from alcohol or drink two or fewer drinks per week after catheter ablation
What this could lead to
If cutting back helps, doctors could give patients clear advice about drinking after ablation to lower the chance of the irregular heartbeat returning.
What could go wrong
Participants may find it hard to stick to the drinking limits, and the trial may not show a clear link between alcohol and recurrence. Results may not apply to people who drink less or have other heart conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 184 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2022

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * AF patients that regularly consume \>5 alcoholic drink (\*12 g of pure alcohol/drink)/week * Paroxysmal or persistent AF * First catheter ablation History of alcohol-induced arrhythmia * Willing to sign the written informed consent Exclusion Criteria: * Binge drinkers (alcohol dependence) * Non-drinkers * LVEF \<35% * Psychiatric conditions * MoCA score ≤ 17 on Montreal Cognitive Assessment (MoCA) * Patients with established dementia * Medically unstable patients (acute/unstable or poorly controlled problems that would demand focused, relatively urgent or emergent medical attention) * Unwilling for alcohol-abstinence * Long-standing persistence AF * Patient under legal protection * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrial fibrillation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atrial fibrillation Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrial fibrillation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Texas Cardiac Arrhythmia Institute, St. David's Medical Center

    RECRUITING

    Austin, Texas, 78705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.